Athersys Stock Forecast for 2023 - 2025 - 2030

Updated on 05/01/2024

Stock Rating
6
Price Target
$0.00
Consensus
-
Upside
0.00%
Analysts
1
Stock Rating
6
Upside
0.00%
Analysts
1
Price Target
$0.00
-

Athersys Fair Value Forecast for 2023 - 2025 - 2030

In the last three years, Athersys's Price has grown, rising from $0.00 to $0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach $0.00 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
$0.00
2025 Fair Value Forecast
$0.00
2026 Fair Value Forecast
$0.00
2027 Fair Value Forecast
$0.00
2028 Fair Value Forecast
$0.00
2029 Fair Value Forecast
$0.00
2030 Fair Value Forecast
$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
MDXG Stock Forecast MiMedx Group Buy 6
$6.16 Buy/Sell $11.85 94.81%
OFIX Stock Forecast Orthofix Medical Hold 10
$13.00 Buy/Sell $18.00 15.38%
AXGN Stock Forecast AxoGen Buy 6
$6.41 Buy/Sell $12.50 118.41%
LCTX Stock Forecast Lineage Cell Therapeutics Outperform 11
$1.09 Buy/Sell $5.40 358.72%
CGEN Stock Forecast Compugen Buy 7
$1.93 Buy/Sell $4.00 159.07%

Athersys Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Athersys's Revenue has grown, rising from $1.44M to $5.33M – a growth of 270.14%. According to 1 prominent analysts, Athersys's Revenue will fall by 100.00% in the next year, reaching $0.00. By 2030, professionals believe that Athersys's Revenue will decrease by 100.00%, reaching $0.00 – a concerning trend for the company.

2024 Rev Forecast
$0.00
2025 Rev Forecast
$0.00
2026 Rev Forecast
$0.00
2027 Rev Forecast
$0.00
2028 Rev Forecast
$0.00
2029 Rev Forecast
$0.00
2030 Rev Forecast
$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
XTNT Stock Forecast Xtant Medical Holdings Buy 0
$0.89 Buy/Sell $1.93 116.85%
BRTX Stock Forecast BioRestorative Therapies Outperform 0
$1.42 Buy/Sell $15.00 639.44%
PRED Stock Forecast Predictive Technology Group - 0
$0.00 Buy/Sell $7.00 0.00%

Athersys Dividend per Share Forecast for 2023 - 2025 - 2030

Athersys Free Cash Flow Forecast for 2023 - 2025 - 2030

Athersys EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Athersys's EBITDA has gone down from $-77.44M to $-75.59M – a 2.39% drop. For the next year, analysts predict that EBITDA will reach $-79.87M – an increase of 5.67%. Over the next eight years, experts believe that Athersys's EBITDA will grow at a rate of 5.96%.

2023 EBITDA Forecast
$-79873433.33
2024 EBITDA Forecast
$-79436791.90
2025 EBITDA Forecast
$-81679557.32
2026 EBITDA Forecast
$-79621232.48
2027 EBITDA Forecast
$-79724740.08
2028 EBITDA Forecast
$-79647672.83
2029 EBITDA Forecast
$-80327332.97
2030 EBITDA Forecast
$-80091706.13

Athersys EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Athersys's EBIT has fallen from $-78.33M to $-66.97M – a 14.50% decrease. According to 1 analysts, Athersys's EBIT will fall by 61.62% in the next year, reaching $-25.70M. Professionals believe that By 2030, Athersys's EBIT will fall to $-43.33M – a 35.30% decrease from its current value.

2024 EBIT Forecast
$-25700000.00
2025 EBIT Forecast
$-27200000.00
2026 EBIT Forecast
$-43911680.00
2027 EBIT Forecast
$-61038698.92
2028 EBIT Forecast
$-46464692.24
2029 EBIT Forecast
$-41082532.06
2030 EBIT Forecast
$-43329746.56

Athersys EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last three years, Athersys's EPS has grown, rising from $-10.50 to $0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach $-0.75 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
$-0.75
2025 EPS Forecast
$-0.70
2026 EPS Forecast
$-0.72
2027 EPS Forecast
$-0.49
2028 EPS Forecast
$-0.57
2029 EPS Forecast
$-0.63
2030 EPS Forecast
$-0.68